Relationships with the drug industry: Collaboration to improve care

BMJ 2009; 338 doi: 10.1136/bmj.b232 (Published 3 February 2009)
Cite this as: BMJ 2009;338:b232

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gordon Coutts, vice president and general manager
  1. 1Schering Plough UK, Welwyn Garden City, Hertfordshire AL7 1TW
  1. gordon.coutts{at}spcorp.com

    The relationship between the drug industry, academia, healthcare professionals, and patients has reached an all time low and few doubt that it is in the interests of all parties to improve it. A recent report from the Royal College of Physicians attempts to define a path towards achieving a more productive relationship. Here we set out five contrasting views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it (doi:10.1136/bmj.b222, doi:10.1136/bmj.b211, doi:10.1136/bmj.b252, doi:10.1136/bmj.b234)

    Healthcare professionals and patients need to have the most up to date information on all the treatment options available to them, including medicines. There is therefore a legitimate place for a responsible relationship between the drug industry and the NHS, prescribers, and patients. This relationship should support the promotion …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL